Irritable bowel syndrome (IBS) is a chronic and debilitating functional gastrointestinal
disorder that affects 9%-23% of the population across the world. The percentage of patients …

Despite years of advising patients to alter their dietary and supplementary fiber intake, the
evidence surrounding the use of fiber for functional bowel disease is limited. This paper …

Although efficacy and effectiveness studies are both important when evaluating
interventions, they serve distinct purposes and have different study designs. Unfortunately …

Background&Aims: The aim of this study was to compare the response of symptoms and
cytokine ratios in irritable bowel syndrome (IBS) with ingestion of probiotic preparations …

The irritable bowel syndrome (IBS) is part of the larger group of functional gastrointestinal
(GI) disorders that, despite differences in location and symptom patterns, share common …

Although functional somatic syndromes (FSS) show substantial overlap, treatment research
is mostly confined to single syndromes, with a lack of valid and generally accepted …

Irritable bowel syndrome (IBS) remains a clinical challenge in the 21 st century. It's the most
commonly diagnosed gastrointestinal condition and also the most common reason for …

Irritable bowel syndrome (IBS) is the most common disorder referred to gastroenterologists
and is characterized by altered bowel habits, abdominal pain, and bloating. Visceral …

Background & Aims: Observational studies suggest dietary fructose restriction might lead to
sustained symptomatic response in patients with irritable bowel syndrome (IBS) and fructose …

Background Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder.
The role of pharmacotherapy for IBS is limited and focused mainly on symptom control …